IQV
IQV — Positioned as a potential beneficiary if regulated, skeptical-buyer markets reward AI + services incumbents over pure SaaS providers. Investment stance: Buy (see conviction and caveats below).
Recent proof-backed thesis calls
We have one active recommendation tied to YC-style guidance on building AI services businesses: services + AI can work in regulated markets (e.g., FDA/regulatory consulting, legal), but economics differ from SaaS. The guidance emphasizes selling outcomes, avoiding low-margin pilots, and accounting for human-in-the-loop costs.
YC-style guidance on building AI services businesses: services + AI can work in regulated, skeptical-buyer markets (e.g., FDA/regulatory consulting, legal services), but economics differ from SaaS (gross margins often ~30% vs 50%+). Warns against “buy a services firm and sprinkle AI” roll-up strategies and against pilots with zero/negative margins; stresses selling outcomes vs seats and human-in-the-loop costs.
Current stance
Current recommendation: buy. Rationale: IQV stands to benefit if regulated verticals continue to favor incumbents delivering AI-augmented services rather than pure SaaS solutions. Confidence is moderate; monetization is expected to be services-driven rather than SaaS-like margin expansion.
- beneficiary via Regulated verticals favor AI + services incumbents over pure SaaS economics from https://www.youtube.com/@ycombinator (confidence 0.53)
Top authors on this asset
Active and historical ticker theses
Active play: 'A Founder's Playbook for AI Services Businesses' — thesis: regulated verticals favor AI + services incumbents over pure SaaS economics. Expect monetization via services revenue with different margin profiles than SaaS.
Unlock full asset monitoring
Track operational indicators that demonstrate services monetization (signed engagements, outcomes pricing, gross-margin trends) and monitor evidence of AI augmenting rather than replacing high-touch service delivery.